Combined chemoradiotherapy for early glottic cancer in clinical practice in Japan: analysis of 10 institutions.

AIM To conduct a retrospective analysis regarding treatment strategies for early glottic cancer (GC) at ten institutions. PATIENTS AND METHODS A questionnaire-based survey was used to obtain personal and medical information on patients who started radiation therapy for T1 or T2 GC between January 2000 and December 2005. RESULTS A total of 279 patients were registered for the survey, of whom 124 patients were classified as T1a, with 65 patients as T1b and 87 patients as T2. The rates of chemoradiotherapy for T1a, T1b and T2 were 24%, 23% and 60%, respectively. A comparison of results for academic and non-academic hospitals showed statistically different rates of combination therapy for T1a (6.9% vs. 39.3%, respectively; p<0.001) and T1b (11.4% vs. 36.6%, respectively; p<0.05) but not for T2 (70.0% vs. 54.4%, respectively; p = 0.158). CONCLUSION In clinical practice, combined chemoradiotherapy was performed for early GC at most institutions in Tokai District, Japan.

[1]  W. Mendenhall,et al.  T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[2]  S. Yom,et al.  Larynx and Hypopharynx Cancer , 2010 .

[3]  D. DavidS.ShimmM..  Perez and Brady's Principles and Practice of Radiation Oncology , 2008 .

[4]  B. Emami,et al.  Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. , 2007, International Journal of Radiation Oncology, Biology, Physics.

[5]  Y. Niibe,et al.  Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. , 2007, Anticancer research.

[6]  K. Nagata,et al.  A Phase I Study of Concurrent Chemoradiotherapy with S-1 for T2N0 Glottic Carcinoma , 2007, Oncology.

[7]  Christopher U. Jones,et al.  26: A Randomized Trial of Hyperfractionation Versus Standard Fractionation In T2 Squamous Cell Carcinoma of The Vocal Cord , 2006 .

[8]  K. Ang,et al.  American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Y. Kitamoto,et al.  Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. , 2006, International journal of radiation oncology, biology, physics.

[10]  H. Yamazaki,et al.  Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. , 2006, International journal of radiation oncology, biology, physics.

[11]  Y. Itoh,et al.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer , 2006, Radiation Medicine.

[12]  L. Livi,et al.  Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. , 2005, International journal of radiation oncology, biology, physics.

[13]  L. Livi,et al.  Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. , 2005, International journal of radiation oncology, biology, physics.

[14]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[15]  A. Garden,et al.  Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? , 2003, International journal of radiation oncology, biology, physics.

[16]  Z. Liao,et al.  Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences. , 2002, International journal of radiation oncology, biology, physics.

[17]  T. Teshima,et al.  Patterns of Care Study quantitative evaluation of the quality of radiotherapy in Japan , 2002, Cancer.

[18]  M. Masuda,et al.  “FAR” chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma , 2002, Head & neck.

[19]  K. Johansson,et al.  Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. , 2002, International journal of radiation oncology, biology, physics.

[20]  W. Mendenhall,et al.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Agarwal,et al.  Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. , 2000, International journal of radiation oncology, biology, physics.

[22]  S. Fisher,et al.  P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. , 2000, International journal of radiation oncology, biology, physics.

[23]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.